December 16, 2011
Sanofi-aventis K.K. appealed on December 15 to the Intellectual Property (IP) High Court against the invalidity of the use patents of the antiallergic Allegra (fexofenadine HCl) ruled by the Japan Patent Office (JPO), claiming the annulment of the ruling. According...read more